Janux Therapeutics Balance Sheet (2020-2026) | JANX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)	0.04M	0.07M	0.13M	0.21M	0.32M	0.57M	0.97M	1.41M	1.88M	2.38M	2.91M	3.45M	3.93M	4.44M	4.95M	5.47M	6.01M	6.50M	6.97M	7.35M
Receivables - Accured (Quarter)	0.00M	28.00M	0.20M	0.10M	0.30M	0.30M	0.70M	0.70M	1.50M	1.70M	2.20M	3.90M	4.60M	4.50M	5.40M	5.60M	5.70M	6.30M	6.40M	7.50M
Assets
Current Assets
Cash & Equivalents (Quarter)	251.62M	348.12M	35.58M	55.13M	58.40M	64.75M	51.43M	30.36M	33.70M	17.15M	19.20M	212.80M	14.66M	26.75M	430.61M	73.74M	52.45M	48.39M	52.33M	51.83M
Receivables - Net (Quarter)	0.38M					0.50M		0.80M				0.52M	7.50M							35.00M
Receivables - Other (Quarter)											2.16M	3.89M	4.56M	4.45M	5.38M	5.58M	5.69M	6.32M	6.43M	7.46M
Receivables (Quarter)	0.38M					0.50M		0.80M			2.16M	4.41M	12.06M						6.43M	42.46M
Prepaid Assets (Quarter)	2.04M	2.08M	2.05M	3.45M	3.77M	5.07M	5.42M	3.77M	6.01M	5.48M	2.32M	1.84M	2.41M	2.68M	2.35M	2.88M	1.61M	1.19M	1.85M	0.89M
Current Assets (Quarter)	396.61M	389.59M	377.02M	364.65M	358.06M	344.33M	332.44M	321.40M	309.30M	355.19M	349.24M	658.67M	661.94M	666.32M	1,033.67M	1,023.34M	1,005.55M	998.09M	975.89M	1,002.05M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.21M	1.12M	1.41M	2.66M	3.52M	6.51M	7.09M	7.20M	7.38M	7.32M	7.00M	6.52M	5.94M	5.37M	4.86M	4.95M	4.69M	4.31M	3.85M	3.55M
Other Non-Current Assets (Quarter)		0.14M	0.39M	0.34M	0.82M	0.82M	0.82M	0.82M	0.82M	2.31M	0.82M	2.52M	0.82M	2.82M	2.88M	2.79M	0.82M	2.63M	2.61M	0.82M
Non-Current Assets (Quarter)	0.21M	1.50M	2.81M	3.94M	27.30M	31.43M	31.57M	31.56M	32.20M	31.66M	31.17M	30.32M	29.47M	28.70M	27.85M	27.43M	26.66M	26.68M	25.68M	26.18M
Assets (Quarter)	396.82M	391.08M	379.82M	368.60M	385.37M	375.76M	364.01M	352.96M	341.50M	386.85M	380.41M	688.98M	691.41M	695.02M	1,061.52M	1,050.77M	1,032.21M	1,024.77M	1,001.57M	1,028.22M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.35M	3.61M	2.46M	1.94M	3.00M	2.87M	2.16M	2.05M	1.91M	2.50M	2.42M	2.25M	1.25M	2.46M	4.03M	2.35M	3.48M	3.40M	4.97M	3.38M
Payables (Quarter)	0.35M	3.61M	2.46M	1.94M	3.00M	2.87M	2.16M	2.05M	1.91M	2.50M	2.42M	2.25M	1.25M	2.46M	4.03M	2.35M	3.48M	3.40M	4.97M	3.38M
Accumulated Expenses (Quarter)	2.29M	0.78M	1.17M	5.07M	1.19M	4.74M	8.18M	7.74M	6.53M	6.83M	3.54M	3.68M	5.92M	8.35M	6.20M	13.34M	2.35M	17.58M	4.59M	12.39M
Other Accumulated Expenses (Quarter)	0.20M	0.52M	0.48M	0.33M	0.35M	0.61M	0.62M	0.73M	1.02M	0.61M	0.55M	0.81M	0.72M	0.78M	0.92M	0.93M	0.59M	0.55M	0.94M	0.84M
Current Leases (Quarter)		0.21M	0.19M	0.15M	0.09M		0.76M	1.36M	1.41M	1.46M	1.52M	1.57M	1.63M	1.69M	1.75M	1.81M	1.87M	2.28M	2.39M	2.47M
Current Deferred Revenue (Quarter)	5.07M	5.26M	5.16M	4.65M	5.37M	5.91M	5.41M	4.93M	5.34M	3.65M	1.71M	0.97M	0.09M							37.59M
Total Current Liabilities (Quarter)	9.21M	12.47M	12.80M	12.52M	12.99M	16.34M	16.51M	16.11M	17.90M	14.47M	13.03M	10.61M	11.54M	17.17M	17.46M	17.50M	21.38M	27.83M	25.00M	58.91M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)	2.82M	1.84M	0.70M		5.29M	3.82M	2.22M	1.39M	0.31M											8.68M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)		0.02M			23.27M	24.09M	24.54M	24.18M	23.82M	23.43M	23.02M	22.61M	22.19M	21.74M	21.28M	20.80M	20.32M	20.38M	19.75M	19.10M
Total Liabilities (Quarter)	12.03M	14.33M	13.50M	12.52M	41.55M	44.24M	43.27M	41.69M	42.03M	37.90M	36.06M	33.22M	33.73M	38.91M	38.73M	38.30M	41.70M	48.21M	44.74M	86.69M
Shareholder's Equity
Common Equity (Quarter)	384.80M	376.75M	366.33M	356.08M	343.81M	331.51M	320.74M	311.26M	299.47M	348.95M	344.35M	655.76M	657.68M	656.10M	1,022.78M	1,012.47M	990.52M	976.55M	956.82M	941.53M
Shareholder's Equity (Quarter)	384.80M	376.75M	366.33M	356.08M	343.81M	331.51M	320.74M	311.26M	299.47M	348.95M	344.35M	655.76M	657.68M	656.10M	1,022.78M	1,012.47M	990.52M	976.55M	956.82M	941.53M
Liabilities and Shareholders Equity (Quarter)	396.82M	391.08M	379.82M	368.60M	385.37M	375.76M	364.01M	352.96M	341.50M	386.85M	380.41M	688.98M	691.41M	695.02M	1,061.52M	1,050.77M	1,032.21M	1,024.77M	1,001.57M	1,028.22M
Retained Earnings (Quarter)	-23.23M	0.02M	-0.27M	-60.82M	-77.70M	-94.41M	-1.53M	-127.90M	-145.40M	-157.00M	-168.76M	-183.50M	-189.50M	-217.50M	2.16M	-261.26M	-295.10M	-319.40M	4.32M	-375.70M
Treasury Shares (Quarter)													0.02M	0.08M	0.34M	0.60M	0.70M	0.70M	0.70M	1.16M
Shares Outstanding (Quarter)	13.11M	41.17M	41.24M	41.39M	41.50M	41.55M	41.62M	41.80M	41.87M	46.15M	46.25M	5.40M	52.16M	52.34M	59.06M	59.17M	59.30M	60.12M	60.38M	60.87M

Research Tools

Developers

Janux Therapeutics Balance Sheet (2020-2026) | JANX

Research Tools

Developers

Janux Therapeutics Balance Sheet (2020-2026) | JANX

Create an account

Sign In

Reset Password